AMGN analyst estimates
Amgen (AMGN) analyst ratings, the average price target and its range, and every firm's latest call.
- 25 firms rate AMGN: 8 buy, 15 hold, 2 sell.
- The average price target is $426.29 from None analysts, from $230.00 to $531.00.
AMGN analyst ratings and price targets
| Date | Firm | Call | Target |
|---|---|---|---|
| Nov 12, 2026 | Argus Research | Amgen (AMGN) PT Raised to $515 at Argus | $515.00 |
| Nov 6, 2026 | Freedom Broker | Freedom Broker Downgrades Amgen (AMGN) to Hold | $470.00 |
| Nov 4, 2026 | Wells Fargo | Amgen (AMGN) PT Raised to $460 at Wells Fargo | $460.00 |
| Nov 4, 2026 | Canaccord Genuity | Amgen (AMGN) PT Raised to $440 at Canaccord | $440.00 |
| Nov 4, 2026 | Truist Financial | Amgen (AMGN) PT Raised to $398 at Truist Securities | $398.00 |
| Nov 4, 2026 | RBC Capital | Amgen (AMGN) PT Raised to $470 at RBC Capital | $470.00 |
| Nov 4, 2026 | Bernstein | Amgen (AMGN) PT Raised to $400 at Bernstein SocGen Group | $400.00 |
| Nov 4, 2026 | TD Cowen | Amgen (AMGN) PT Raised to $531 at TD Cowen | $531.00 |
| Nov 4, 2026 | Cantor Fitzgerald | Amgen (AMGN) PT Raised to $465 at Cantor Fitzgerald | $465.00 |
| Oct 23, 2026 | Oppenheimer | Amgen (AMGN) PT Raised to $480 at OppenheimerMember Login | $480.00 |
| Oct 21, 2026 | Barclays | Amgen price target raised to $400 from $380 at Barclays | $400.00 |
| Oct 13, 2026 | Guggenheim | Amgen price target lowered to $378 from $388 at Guggenheim | $378.00 |
| Oct 12, 2026 | Wells Fargo | Amgen price target lowered to $430 from $435 at Wells Fargo | $430.00 |
| Oct 12, 2026 | BMO Capital | Amgen price target lowered to $415 from $450 at BMO Capital | $415.00 |
| Oct 8, 2026 | RBC Capital | Amgen price target raised to $430 from $400 at RBC Capital | $430.00 |